Eikon Therapeutics, Inc. Common Stock (EIKN) is a publicly traded the market company. As of October 16, 2026, EIKN trades at $7.75 with a market cap of $379.70M and a P/E ratio of -4.49. EIKN moved +2.77% today. Year to date, EIKN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $6.45 to $17.40. Analyst consensus is strong buy with an average price target of $31.00. Rallies surfaces EIKN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for EIKN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $7.75 |
| Market Cap | $379.70M |
| P/E Ratio | -4.49 |
| EPS | $-1.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.40 |
| 52-Week Low | $6.45 |
| Volume | 5.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.04M |
| Net Income | $-88.41M |
| Gross Margin | 0.00% |
3 analysts cover EIKN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.00.